ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2013

A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.

T Y Seiwert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.